Hydrochloric Acid → 4-(1-Ethyl-3,5-dimethyl-1H-pyrazol-4-ylmethyl)-3'-(4-fluoro-phenyl)-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl hydrochloride
Reaction equation
[ClH:1].Cl.[F:3][C:4]1[CH:9]=[CH:8][C:7]([C:10]2[C:11]([N:16]3[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]3)=[N:12][CH:13]=[CH:14][N:15]=2)=[CH:6][CH:5]=1.[CH2:22]([N:24]1[C:28]([CH3:29])=[C:27]([CH:30]=O)[C:26]([CH3:32])=[N:25]1)[CH3:23].C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].[OH-].[Na+].Cl>O1CCCC1.C(#N)C.C(Cl)Cl>[ClH:1].[CH2:22]([N:24]1[C:28]([CH3:29])=[C:27]([CH2:30][N:19]2[CH2:18][CH2:17][N:16]([C:11]3[C:10]([C:7]4[CH:8]=[CH:9][C:4]([F:3])=[CH:5][CH:6]=4)=[N:15][CH:14]=[CH:13][N:12]=3)[CH2:21][CH2:20]2)[C:26]([CH3:32])=[N:25]1)[CH3:23]Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 3
Procedure
To a stirred suspension of 3′-(4-fluoro-phenyl)-3,4,5,6-tetrahydro-2H-[1,2′]bipyrazinyl dihydrochloride (0.3 g, 0.906 mmol, 1 eq) and 1-ethyl-3,5-dimethyl-1H-pyrazole-4-carbaldehyde (207 mg, 1.36 mmol, 1.5 eq) in tetrahydrofuran (10 mL) add sodium triacetoxyborohydride (480 mg, 2.26 mmol, 2.5 eq) in one portion as a solid. Stir the mixture at room temperature under nitrogen for 19 hr. Add 2M aqueous sodium hydroxide solution (10 ml) and DCM (20 ml) separate and extract the aqueous layer with DCM (20 ml). Combine the organics, dry over magnesium sulfate, filter and concentrate. Purify by high pH reverse phase HPLC. Dissolve this material (49 mg, 0.12 mmol), in the minimum quantity of 50% aqueous acetonitrile. Add 2M aqueous hydrogen chloride (60 μL, 0.12 mmol) and lyophilize to give the title compound (58 mg, 15%). MS (ES): m/z=395.2 [M+H]+.
Workup
- customseparate
- extractionextract the aqueous layer with DCM (20 ml)
- dry with materialCombine the organics, dry over magnesium sulfate
- filtrationfilter
- concentrationconcentrate
- customPurify by high pH reverse phase HPLC
Sources & evidence
- ORD record
- ord-b8e8b01beb84434e9f3da647114b4aad
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08202873B2
Reaction notes
Loading…